Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
It will be done a randomized triple-blind study comparing 0,2% polidocanol versus 75%
hypertonic glucose of sclerotherapy in lower limbs´ reticular veins. It will be included only
adult women with reticular veins on the side of the thighs and mild venous insufficiency
(CEAP 1). The primary endpoint will be efficacy, and secondary will be safety.
Phase:
Phase 4
Details
Lead Sponsor:
UPECLIN HC FM Botucatu Unesp
Collaborator:
Fundação de Amparo à Pesquisa do Estado de São Paulo